Five samples of CSP cough syrup manufactured by Maiden Pharmaceuticals Limited at its plant at Manpura in Himachal Pradesh’s Baddi have been found to be substandard, according to the monthly alert issued today by national regulator Central Drugs Standard Control Organisation (CDSCO).
It was brought up once more in Gambia that Maiden Pharmaceuticals' cough syrups may have contributed to the deaths of 70 children there.Parliamentary committee suggestion According to the BBC, a parliamentary committee in the Gambia has suggested
A parliamentary committee in The Gambia has recommended prosecution of an Indian manufacturer of cough syrups suspected of causing the deaths of at least 70 children in the West African country.After weeks of investigation, the Gambian .